A detailed history of Allspring Global Investments Holdings, LLC transactions in Repligen Corp stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 254,054 shares of RGEN stock, worth $34.6 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
254,054
Previous 278,218 8.69%
Holding current value
$34.6 Million
Previous $35.1 Million 7.8%
% of portfolio
0.06%
Previous 0.06%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$119.79 - $167.35 $2.89 Million - $4.04 Million
-24,164 Reduced 8.69%
254,054 $37.8 Million
Q2 2024

Jul 26, 2024

SELL
$120.0 - $182.95 $6.91 Million - $10.5 Million
-57,618 Reduced 17.16%
278,218 $35.1 Million
Q1 2024

Apr 18, 2024

BUY
$170.78 - $208.42 $10.2 Million - $12.5 Million
59,903 Added 21.71%
335,836 $61.8 Million
Q4 2023

Jan 25, 2024

BUY
$114.17 - $185.35 $1.68 Million - $2.72 Million
14,693 Added 5.62%
275,933 $49.6 Million
Q3 2023

Oct 27, 2023

BUY
$138.78 - $176.51 $36.3 Million - $46.1 Million
261,240 New
261,240 $41.5 Million
Q1 2023

Apr 13, 2023

SELL
$154.26 - $198.1 $17.3 Million - $22.2 Million
-112,233 Reduced 37.17%
189,747 $31.9 Million
Q4 2022

Jan 23, 2023

SELL
$162.42 - $220.56 $22.3 Million - $30.3 Million
-137,443 Reduced 31.28%
301,980 $51.1 Billion
Q3 2022

Oct 26, 2022

SELL
$160.42 - $256.21 $17.4 Million - $27.8 Million
-108,627 Reduced 19.82%
439,423 $82.2 Million
Q2 2022

Jul 25, 2022

SELL
$140.68 - $188.02 $8.69 Million - $11.6 Million
-61,750 Reduced 10.13%
548,050 $89 Million
Q1 2022

May 02, 2022

SELL
$161.19 - $257.96 $34.8 Million - $55.7 Million
-215,772 Reduced 26.14%
609,800 $115 Million
Q4 2021

Jan 28, 2022

BUY
$247.59 - $304.47 $204 Million - $251 Million
825,572 New
825,572 $219 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.57B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.